| Date |
Research Question / Title |
Unique ID |
Research Team |
|
April 6, 2020
|
What is the evidence for the effectiveness of face masks for preventing the spread of COVID-19 in the community?
|
EOC040601-01 ESR
|
EOC
|
|
April 6, 2020
|
What is the evidence for the effectiveness of face masks for preventing the spread of COVID-19 in the community?
|
EOC040601 RR
|
EOC
|
|
July 10, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001-01 ESR
|
EOC
|
|
July 27, 2020
|
What is the definition of an outbreak versus a cluster for COVID-19 in different clinical and community settings in Canada, the US, and the UK?
|
EOC071001 RR
|
EOC
|
|
September 14, 2020
|
What is the evidence surrounding facial mask exemptions for COVID-19?
|
EOC091101-01 ESR
|
EOC
|
|
September 17, 2020
|
What evidence is there to support medical exemptions for mask wearing?
|
EOC091101 RR
|
EOC
|
|
September 25, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401-01 ESR
|
EOC
|
|
September 29, 2020
|
What is the evidence that runny nose or sneezing are symptoms of COVID-19?
|
EOC092401 RR
|
EOC
|
|
October 13, 2020
|
What are the age restrictions for healthcare workers/volunteers?
|
EOC100801-01 ESR
|
EOC
|
|
October 19, 2020
|
What are the age restrictions for healthcare workers/volunteers?
|
EOC100801 RR
|
EOC
|
|
January 21, 2021
|
How safe are the Pfizer and Moderna vaccinations?
|
EOC011901-01 ESR
|
EOC
|
|
January 24, 2021
|
How safe are the Pfizer and Moderna vaccinations?
|
EOC011901 RR
|
EOC
|
|
March 11, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001-01 ESR
|
EOC
|
|
March 18, 2021
|
What are the differences between COVID-19 vaccines and how should they be distributed based on population group(s)?
|
EOC031001 RR
|
EOC
|
|
April 1, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 ESR
|
EOC
|
|
April 21, 2021
|
What are the risks or benefits of extended intervals between doses of COVID-19 vaccines compared to recommended dosing in extremely vulnerable populations?
|
EOC210302 RR
|
EOC
|
|
June 1, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 ESR
|
EOC
|
|
June 21, 2021
|
What are the ethical/legal aspects of vaccine requirements?
|
EOC210503 RR
|
EOC
|
|
September 29, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 ESR
|
EOC
|
|
October 7, 2021
|
What is the current evidence and recommendations regarding COVID-19 vaccine booster shots (exceeding 2 doses) for the general population?
|
EOC210902 RR
|
EOC
|
